BOCA RATON, Fla., Oct. 22, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, November 1, 2018 at 4:30 p.m. Eastern time to discuss the financial results […]
Dermatology Times – As an add-on to Mohs surgery, this treatment may have its benefits
Superficial Radio Therapy and our CEO, Joe Sardano, are making headlines with Dermatology Times. This article highlights the benefits of using SRT alongside Mohs surgery when treating skin cancer patients. With 80 percent of skin cancers appearing on the face and neck, a less invasive approach is very sought out by sufferers. Read the full […]
Physician Spotlight – January 2019
Dr. Steven K. Grekin, D.O. is the founder and Medical Director of The Grekin Skin Institute, a dermatological practice providing care within many segments of the medical market in Michigan. His primary mission is to help his patients put their best face forward by delivering extraordinary care and medical treatment. Having completed his undergraduate studies […]
Sensus Healthcare Brings Groundbreaking SRT-100 Vision System to Israel’s Largest Hospital for Skin Cancer and Keloid Treatment
SRT-100 Vision Coming to Patients at Sheba Medical Center Near Tel Aviv BOCA RATON, Fla., Oct. 17, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), today announced that the Company has shipped its third […]
South Florida Business Journal Recognizes Sensus Healthcare’s Chief Technology Officer at 2018 Technology Awards
BOCA RATON, Fla., Oct. 16, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), today announced that the South Florida Business Journal has recognized the Company’s Chief Technology Officer, Kal Fishman, as a finalist at […]
Top Reasons to Visit Sensus Healthcare at ASTRO
ASTRO’s Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year. This scientific program is the ideal platform to bring together physicians, scientists and researchers from all oncology disciplines to exchange ideas, promote multidisciplinary care and address the educational and professional development interests of attendees. […]
The Dermatologist – Empowering the Patient: Educating Patients on Different Skin Cancer Treatments
It is crucial for dermatologists to be at the frontline of the skin cancer epidemic. Jeffrey S. Fromowitz, MD, FAAD, understands the difficulty educating patients and providing physicians with the different skin cancer treatments that currently are available. Surgery is typically coupled with downtime and invasive procedures. Since many skin cancer treatment recipients are seniors, the […]
The Importance of Protecting Your Skin this Fall
As summer comes to an end, the weather gets cooler and the days grow shorter, leaving many people to store their sunscreen for the upcoming season. However, even in the fall months, ultraviolet (UV) protection is important in protecting your skin. In fact, UVA rays—which make up 95% of all UV rays—are almost as equally […]
2018 Aesthetic Awards: Non-Physician Non-Surgical Innovator of the Year Award
Over the past several years, Mr. Sardano, CEO of Sensus Healthcare, has worked tirelessly to offer a non-surgical solution for non-melanoma skin cancer and an effective treatment for keloid scars. The state-of-the-art Superficial Radio Therapy (SRT) technology is the non-surgical treatment option dermatologists and oncologists have been waiting for. Upon receiving the “Non-Physician Non-Surgical Innovator of […]
Sensus Healthcare, Inc. Announces Underwriters’ Exercise of Option
BOCA RATON, Fla., Sept. 21, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it has issued an additional 330,882 shares of its common stock pursuant to the exercise in full of the underwriters’ option received in connection with Sensus’ recently completed public offering of its common stock. After giving effect to the full […]
CEO Money: Dr Ellen Turner is using a non-invasive, painless method to treat skin cancer
Dr. Ellen Turner discusses with CEO Money host, Michael Yorba, the non-invasive and pain free benefits of treating skin cancer with Superficial Radio Therapy. With Dr. Turner’s two dermatology practice locations in the Dallas area, she knows that one in three Texans will develop skin cancer in their lifetime. Check out the video below or […]
Sensus Healthcare, Inc. Announces Closing of Public Offering of Common Stock
BOCA RATON, Fla., Sept. 17, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it completed a public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at a public offering price of $6.80 per share. All of the shares were offered by Sensus. The shares are listed on The […]
Sensus Healthcare, Inc. Announces Pricing of Public Offering of Common Stock
BOCA RATON, Fla., Sept. 13, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it has priced an underwritten public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at a public offering price of $6.80 per share. Sensus has granted a 30-day option to purchase up to an additional […]
Sensus Healthcare, Inc. Announces Commencement of Public Offering of Common Stock
BOCA RATON, Fla., Sept. 12, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it commenced a public offering of its common stock, par value $0.01 per share. B. Riley FBR is serving as the lead underwriter and sole book-running manager for the offering. Sensus intends to use the net proceeds from the offering […]
Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting
BOCA RATON, Fla., Sept. 7, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, participated at the National Cancer Care Alliance (NCCA) Leadership Board and Practice Quarterly […]
Sensus Healthcare to Participate in Two Upcoming Investor Conferences
BOCA RATON, Fla., Aug. 27, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, will participate at two investor conferences in September 2018, as follows: Annual B. […]
What You Should Know About Your Family’s History of Skin Cancer
Do you know your family’s history of skin cancer? If one or more of your parents, siblings, or children develop skin cancer, you have a higher risk of developing skin cancer than a person with no family history of the disease. In fact, according to Sun & Skin News, a Skin Cancer Foundation publication, about […]
Making Sense of the Link Between Skin Color and Skin Cancer
While those with lighter skin tones are generally the most at risk for skin cancer, anyone with any skin color can get skin cancer. Unfortunately, many patients are under the impression that those with darker skin are not at risk for skin cancer. “People who have darker skin tones often believe that they’re not at […]
Inc: 19 Ideas on How to Push Yourself to the Next Level
Inc. recently sat down with 19 successful founders and executives to discuss how they push themselves to the next level. When asked about his support system, CEO of Sensus Healthcare, Joe Sardano, said, “One maxim our team hangs onto is, ‘Who packs your parachute?’ This saying comes from an old story originated by a U.S. Navy […]
OWM Industry Spotlight: Joe Sardano
CEO, Chairman and Co-Founder of Sensus Healthcare, Joe Sardano, was recently interviewed for a feature in AAWC‘s research journal, Ostomy Wound Management (OWM). Read the full interview here.